The total number of records retrieved from this search are 12. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_3124	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration0.25 MOI	In-vitro result30% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3125	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration1 MOI	In-vitro result40% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3126	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration2.5 MOI	In-vitro result60% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3127	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration5 MOI	In-vitro result65% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3128	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration10 MOI	In-vitro result70% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3129	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration0.25 MOI	In-vitro result20% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3130	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration1 MOI	In-vitro result35% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3131	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration2.5 MOI	In-vitro result40% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3132	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration5 MOI	In-vitro result50% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3133	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration10 MOI	In-vitro result60% cells are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3135	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with PAI-1 (25 microgram/ml)	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration10 MOI	In-vitro result70% cell are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451
IDOV_3136	Virus nameSendai virus	Virus strainuPA2	Virus genome typeRNA	Virus familyParamyxoviridae	Virus genome modificationDeletion of M, F gen at cytoplasmic location	Virus aloneNo	Virus in combination with drug/radiationVirus in combination with PAI-1 (25 microgram/ml)	Immune gene insertion in viral genomeNo	Source of cell lineJapan collection of research bioresources cell bank	Origin of cell lineHuman anaplastic thyroid carcinoma cell line	Cell line8305C	Concentration of cell line3.0E+3 cells per well	In-vitro toxicityNA	AssayuPA activity assay kit	In-vitro virus concentration10 MOI	In-vitro result60% cell are dead	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedCaspase dependent induction of apoptosis in vivo and in vitro	Immunogenic effectNA	Clinical trialNA	PMID30969451